letter complement cystic fibrosi lieberman report wa consider overlap quantit c3 level cf subject test control group hi control group howev wa compos subject bronchiectasi chronic bronchiti cf rule use proper control group lieberman either place parallel hi diseas control group would provid meaning interpret concern role complement cystic fibrosi agre tendenc c3 higher cf femal cf male although lieberman wa quick dispel ani notion c3a implic aetiolog cf overlook one facet initi studi still make hypothesi feasibl rais c3 level cf oblig heterozygot hann et al report serumc5 wa rais cf patient parent initi data c5 level radial immunodiffus haemolyt studi confirm thi find support hypothesi cf either complementcaus complementmedi disord c3alik molecul c3a bradykinin either alon complex igg give rise physiolog patholog state cf